COMPOUNDING PHARMACISTS SCORE KEY COURT VICTORY OVER FDA

JULY 01, 2006

A federal district court in Midland, Tex, told the FDA to back away from its controversial efforts to restrict pharmacy's right to compound drugs. The decision makes it clear that compounded preparations are not new, unapproved drugs subject to FDA regulation. It "spares drug-compounding pharmacies from having to meet strict FDA regulations on drug safety and efficacy before they can market their products," according to the International Academy of Compounding Pharmacists (IACP).

Describing the court's action as a "landmark" decision, IACP Executive Director L.D. King said that the ruling stops "FDA's encroachment on the authority of state boards of pharmacy in its tracks, and it ensures that patients and physicians will continue to have access to compounded medicines on which they rely."



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.